Mkts

Biofrontera Inc.

NASDAQ: BFRI
$0.53-0.04 (-7.02%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
0.530.59
52-week range
0.541.66
Today
Open0.57
Previous close0.53
Volume—
Valuation
Market cap9.51M
P/E ratio—
EPS (TTM)-0.59
Income & risk
Dividend / yield—
Beta0.96
Avg volume443.6K
Discussion

BFRI News

Stories mentioning BFRI from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue10,08417,0996,9889,0308,58812,5589,0127,839
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development900.00788.00854.00870.001,207782.00669.00621.00
Sales General & Admin10,9948,52310,04710,5288,6538,2038,4257,915
Total Operating Expenses14,40413,13514,27013,97212,910
Operating Income (Loss)(4,320)4,556(6,278)(5,079)(4,547)(1,712)(4,960)(5,071)
Interest Income14.0017.00
Interest Expense620.00
Other Expense(88.00)721.0030.00(264.00)(99.00)4.00(32.00)6.00
Pretax Income(4,752)5,639(6,643)(5,303)(4,204)(1,398)(5,666)(237.00)
Tax Provision(1.00)6.0021.00(1.00)(2.00)3.0020.00
Net Income (Loss)(4,752)5,640(6,649)(5,324)(4,203)(1,396)(5,669)(257.00)
Earnings Per Share (Basic)(0.41)0.55(0.62)(0.57)(0.47)(0.25)(0.98)(0.05)
Earnings Per Share (Diluted)(0.41)0.55(0.62)(0.57)(0.47)(0.25)(0.98)(0.05)
Weighted Average Shares Outstanding (Basic)11,68310,17210,7779,3528,8745,5165,7745,091
Weighted Average Shares Outstanding (Diluted)11,68310,17210,7779,3528,8745,5165,7745,091

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BFRI

Biofrontera Inc. (NASDAQ: BFRI) is a stock listed on the Nasdaq Stock Market under the ticker symbol BFRI. It last traded at $0.5300 (Nov 20, 2026, 4:00 PM ET), down 7.0% on the day. That gives Biofrontera a market capitalisation of $9.5M.

Over the past 52 weeks BFRI has traded between $0.5400 and $1.66.

Revenue for the quarter ended Mar 31, 2026 was $10.1M; a net loss of $4.8M. Revenue was up 17.4% from $8.6M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$10.1M-$4.8M-47.1%
Dec 31, 2025$17.1M$5.6M33.0%
Sep 30, 2025$7.0M-$6.6M-95.1%
Jun 30, 2025$9.0M-$5.3M-59.0%

From Biofrontera’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…